EMCURE PHARMACEUTICALS
|
The Current P/S Ratio of EMCURE PHARMACEUTICALS is 3.25.
| Share Price | ₹1,516.0 | Feb 06,2026 |
| Market Cap | ₹28,742.4 Cr | |
| Sales-TTM | ₹8,850.1 Cr | TTM-Consolidated Results |
| Price/Sales | 3.25x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of EMCURE PHARMACEUTICALS
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹28,742.4 Cr] as on Feb 06,2026
(/) Sales [ ₹8,850.1 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 3.25x ]
Thus, for EMCURE PHARMACEUTICALS , the investors are currently willing to pay '3.25 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of EMCURE PHARMACEUTICALS !
The chart below summarizes the trend in P/S Ratio of EMCURE PHARMACEUTICALS over the last five years.
Historical PS (Price/Sales) ratio chart of EMCURE PHARMACEUTICALS
PS Ratio Performance Analysis for EMCURE PHARMACEUTICALS
- EMCURE PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 0.51x.
- EMCURE PHARMACEUTICALS 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, EMCURE PHARMACEUTICALS 's p/e ratio peaked in Mar2025 at 2.57x.
- EMCURE PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2024 of 0x.
How does EMCURE PHARMACEUTICALS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| EMCURE PHARMACEUTICALS | 8,850.1 | 3.25 | 28,742.4 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 56,809.1 | 7.16 | 406,615.0 |
| DIVIS LABORATORIES LTD | 10,029.0 | 15.95 | 159,943.0 |
| CIPLA LTD | 28,351.1 | 3.79 | 107,499.0 |
| TORRENT PHARMACEUTICALS LTD | 12,248.0 | 10.89 | 133,336.0 |
| DR REDDYS LABORATORIES LTD | 34,682.2 | 2.99 | 103,590.0 |
| MANKIND PHARMA LTD | 13,914.1 | 6.11 | 85,019.3 |
| ZYDUS LIFESCIENCES LTD | 24,493.9 | 3.65 | 89,338.5 |
| LUPIN LTD | 24,750.7 | 4.00 | 99,086.6 |
| AUROBINDO PHARMA LTD | 32,514.5 | 2.13 | 69,182.2 |
| ABBOTT INDIA LTD | 6,714.4 | 8.66 | 58,166.6 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs EMCURE PHARMACEUTICALS 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.13x |
| Max industry PS | 15.95x |
| Median industry PS | 4.00x |
| Average industry PS | 6.23x |
You may also like the below Video Courses